As Goes Texas, So Goes the Nation
Texas made history in the 2021 legislative session with the passage of House Bill 1802, initiating the first publicly funded psychedelic research since the Controlled Substances Act.
This trailblazing effort has sparked a nationwide movement, with five states and the federal government replicating Texas’ approach, unlocking nearly $100 million for psychedelic research.
Stories of Impact
Texas Veterans and former special operators Chase Rowan and Marcus Luttrell share their deeply personal struggles with opioid use and the transformative role plant-medicine ibogaine played in saving their lives.
Leading Psychedelic Policy & Advocacy
Our mission is to improve mental health outcomes by advancing the development and acceptance of psychedelic therapies through education, engagement, advocacy, and policy reform.
We strive to ensure these promising treatments are accessible, safe, and integrated into the healthcare system, providing relief for individuals suffering from severe mental health conditions.
